Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability. | Front Oncol | 2023 | 37188189 | PubTator, text mining | PubMed |
| Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP Workshop. | Am J Clin Pathol | 2023 | 37186259 | PubTator, text mining | PubMed |
| BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5. | Blood Adv | 2023 | 37184294 | PubTator, text mining | PubMed |
| Genome-wide analysis of RNA-binding proteins co-expression with alternative splicing events in mitral valve prolapse. | Front Immunol | 2023 | 37180137 | PubTator, text mining | PubMed |
| Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients. | Front Genet | 2023 | 37152994 | PubTator, text mining | PubMed |
| Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas. | Cancer Discov | 2023 | 37141112 | PubTator, text mining | PubMed |
| A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D. | Int J Hematol | 2023 | 37133636 | PubTator, text mining | PubMed |
| Function and targeting of MALT1 paracaspase in cancer. | Cancer Treat Rev | 2023 | 37126937 | PubTator, text mining | PubMed |
| Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma. | World J Clin Oncol | 2023 | 37124135 | PubTator, text mining | PubMed |
| Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing. | Int J Mol Sci | 2023 | 37108564 | PubTator, text mining | PubMed |
| Organ-based clues for diagnosis of inborn errors of immunity: A practical guide for clinicians. | Immun Inflamm Dis | 2023 | 37102642 | PubTator, text mining | PubMed |
| Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-B Signaling. | Anticancer Res | 2023 | 37097671 | PubTator, text mining | PubMed |
| [Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell Lymphoma Based on Next-Generation Sequencing]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 | 37096512 | PubTator, text mining | PubMed |
| MYD88L265P and MYD88other variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma. | J Cancer Res Clin Oncol | 2023 | 37093346 | PubTator, text mining | PubMed |
| The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4+ T cells resembling iTreg. | Front Immunol | 2023 | 37090735 | PubTator, text mining | PubMed |
| CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis. | Immunobiology | 2023 | 37086690 | PubTator, text mining | PubMed |
| Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma. | Expert Rev Hematol | 2023 | 37086394 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Are Key Determinants of Cancer Cell Invasion in the Earliest Stage of Colorectal Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 37085135 | PubTator, text mining | PubMed |
| IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma. | Cancer Med | 2023 | 37081786 | PubTator, text mining | PubMed |
| Deciphering the spectrum of cutaneous lymphomas expressing TFH markers. | Sci Rep | 2023 | 37081015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=14